Ana Elsa
Huerta Hernández
Publicaciones en las que colabora con Ana Elsa Huerta Hernández (14)
2023
-
Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset
European Journal of Clinical Investigation, Vol. 53, Núm. 10
2021
-
Acquiring sepsis competencies through simulation-based learning bundle during intermediate care unit internship
Medicine, Vol. 100, Núm. 5, pp. e24483
2017
-
Lercanidipine-induced chylous ascites: Case report and literature review
Journal of Clinical Pharmacy and Therapeutics, Vol. 42, Núm. 5, pp. 638-641
2016
-
Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: Potential role of altered collagen metabolism
Journal of Hypertension, Vol. 34, Núm. 1, pp. 130-138
-
Comment on "Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit" by Benoît Dupont et al. [Digestive and Liver Disease 2015;47:675-81]
Digestive and Liver Disease
-
Enterococcal bloodstream infection. Design and validation of a mortality prediction rule
International Journal of Clinical Practice, Vol. 70, Núm. 2, pp. 147-155
2015
-
Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study
Free Radical Biology and Medicine, Vol. 81, pp. 1-12
-
Design and performance of a new severity score for intermediate care
PLoS ONE, Vol. 10, Núm. 6
-
Mortality prediction in patients Undergoing Non-invasive ventilation in intermediate care
PLoS ONE, Vol. 10, Núm. 10
2014
2013
-
Performance of SAPS II and SAPS 3 in Intermediate Care
PLoS ONE, Vol. 8, Núm. 10
-
The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
Cardiovascular Diabetology, Vol. 12, Núm. 1
2011
-
Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico
Revista Espanola de Cardiologia, Vol. 64, Núm. 5, pp. 373-378
2010
-
Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5
Cardiovascular Research, Vol. 88, Núm. 2, pp. 304-313